 (Gut 1994; 35: 746-749) 
hypovolaemic shock, surgical treatment, and death, occurred within 96 hours of admission. After this time, the residual risk of rebleeding was less than 1%. Study of the changes in endoscopic findings before and after rebleeding illustrated that all ulcers with a visible vessel or adherent clot showed at follow up endoscopy were derived from ulcers with initial major stigmata. It is concluded that hypovolaemic shock, a non-bleeding visible vessel, and an adherent clot on an ulcer base are of independent significance in predicting rebleeding. Observation for 96 hours is sufficient to detect most rebleeding episodes after an initial bleed from peptic ulcer. (Gut 1994; 35: 746-749) Bleeding is a common, but serious complication of peptic ulcer disease. About 80-90% of bleeding episodes from peptic ulcers cease spontaneously.' 2 For all these patients, the treatment course is comparatively uncomplicated and the death rate is 4% or less.34 In patients with persistent or recurrent bleeding, however, the death rate can be as high as 30-40%, and emergent endoscopic or surgical intervention is usually required.35 Although there are many published studies that discuss the endoscopic prediction of rebleeding in peptic ulcers,'9 most studies that evaluate the prognostic significance of a visible vessel have not taken into account the important clinical features that probably affect ulcer rebleeding, such as underlying medical illness and severity of bleeding.'0 "In addition, there are no studies that evaluate risk factors for rebleeding by multivariate analysis of clinical, laboratory, and endoscopic parameters.
In clinical practice, determining the optimal stay in hospital for patients with bleeding ulcers is a crucial problem for physicians. A prolonged stay in hospital increases medical costs, while early discharge might result in an increase in preventable death of patients with severe rebleeding. Thus, the results of a study that evaluates the residual risk of rebleeding would possibly be helpful in this decision making.
We performed a prospective study to determine the risk factors and the residual risk for rebleeding peptic ulcer disease after the initial bleed. In addition, we investigated the sequential endoscopic changes of the ulcer from the time of the initial endoscopy to the time of rebleeding. Patients who were haemodynamically stable on admission and had clean ulcer bases as shown by initial endoscopy, were discharged within 24 hours. Patients who had stigmata of bleeding were admitted for close observation and had follow up endoscopies every two days until the disappearance of the stigmata. During the stay in hospital, intravenous H2 blockers were routinely given. The patients who developed rebleeding during the observation period were initially treated with therapeutic endoscopy, and were then given surgery if haemostasis could not be achieved. After discharge, patients received oral H2 blockers and were followed up by telephone every other day. Patients were also requested to return to the outpatient clinic between day 3 and day 7 to check for evidence of rebleeding. The end points of this study were (a) death of the patient, or (b) observation for 10 days. 'Rebleeding' was defined as a subsequent ulcer bleeding episode that occurred after the initial bleed had stopped, as shown by follow up endoscopy or persistent haematemesis or melaena or both, with a change in vital signs. If medical treatment failed to achieve successful haemostasis, emergency surgery was performed.
Patients and methods

PATIENTS
STATISTICS
To determine the independent risk factors for rebleeding in patients who did not have actively bleeding ulcers at initial endoscopy, 16 clinical, laboratory, and endoscopic parameters of bleeding peptic ulcers were analysed by univariate analysis. A p value less than 0 05 was considered to be significant. Those parameters found to be significant by univariate analysis were subsequently assessed by a stepwise logistic regression method to identify those that were independently significant in predicting rebleeding. In addition, estimates of regression coefficients were used to determine the risk of rebleeding. The residual risk of rebleeding was determined by calculating the resulting risk of rebleeding after a specific number of days had passed since admission.
Results
There were 239 patients with peptic ulcer bleeding initially enrolled in the study, with 12 patients dropping out during follow up. Table I shows the basic clinical data of the 227 patients. Stigmata of bleeding were present in the ulcers of 144 patients at initial endoscopy. Twenty three patients with active bleeding were treated by epinephrine local injection. Haemostasis was not achieved in two patients with bleeding visible vessels. They both subsequently had emergency surgery. The other ulcers with active bleeding were controlled at least temporarily with therapeutic endoscopy, with rebleeding occurring during the follow up period in four patients (19%). In three of the patients with severe rebleeding, haemostasis was not achieved by medical treatment and surgical intervention was required. The overall death rate in patients who presented with active bleeding at initial endoscopy was zero.
Two hundred and four patients presented without active bleeding and therefore were not treated with therapeutic endoscopy initially. During the follow up observation period, 17 of these patients rebled (8-3%). Endoscopic treatment failed to achieve haemostasis in five of them, and all five were sent for surgical treatment. Two patients died from surgical complications. The overall death rate in patients without initial active bleeding was 1 0%.
RISK FACTORS OF REBLEEDING
Univariate analysis of the 16 clinical, laboratory, and endoscopic variables in the 204 patients without active bleeding at initial endoscopy showed that seven were significantly associated with rebleeding: history of smoking, presentation with haematemesis, hypovolaemic shock before endoscopy, increased blood urea nitrogen, ulcer size larger than 1 cm, nonbleeding visible vessel, and adherent clot on the ulcer base (Table II) . Multivariate analysis with stepwise logistic regression showed that only hypovolaemic shock, non-bleeding visible vessel, and adherent clot were independently significant in predicting rebleeding (p<0 05) (Table III) . (Fig 2) .
The stigmata of the patients without rebleeding during the study period evolved with a general trend from adherent clots on initial endoscopy through non-bleeding visible vessels before becoming clean bases with an average duration of four days.
Discussion
In bleeding pepetic ulcers, recurrence, and persistence of bleeding are the most important factors that adversely affect prognosis, with their presence resulting in an up to 12-fold increase in death.'2 Several attempts have been made to identify endoscopic findings that are risk factors for rebleeding in pepetic ulcers."9 There are no published works, however, which prospectively evaluate multiple clinical, laboratory, and endoscopic parameters by multivariate analysis, and which quantitatively assesses the risk factors for rebleeding. In this study, univariate analysis showed seven clinical and endoscopic risk factors that are associated with rebleeding, and multi-
SEQUENTIAL CHANGES IN ENDOSCOPIC FINDINGS
Emergency endoscopy was performed for all rebleeding ulcers (n =2 1). In two cases it was too difficult to perform a detailed examination because bleeding obscured the visual field. is erosion of larger vessels. The first type results in oozing of ulcers and the formation of very small clots, -that is, red/black spots. The risk of rebleeding in this situation is quite low, but mild rebleeding might occasionally occur if the small clot drops off before completion of healing of the underlying tissue. In the second case, if an ulcer erodes a larger vessel, the bleeding is usually massive. Although an adherent clot might temporarily plug the bleeding hole during the haemostatic process, massive rebleeding often occurs if the clot drops off too early. By using a series of follow up endoscopies, we confirmed the natural sequential changes of stigmata of bleeding in peptic ulcers, as proposed by Johnston'" -the healing process of stigmata progresses through the sequence of bleeding visible vessel, large red adherent clot, small white adherent clot, and ultimately disappearance of stigmata.
In conclusion, our study shows that: (1) the presence of hypovolaemic shock, a non-bleeding visible vessel, and an adherent clot are independent risk factors in predicting rebleeding in bleeding peptic ulcers; (2) the presence of a nonbleeding visible vessel is the most important factor in the prediction of rebleeding; (3) 
